TENAX THERAPEUTICS, INC. 4
4 · TENAX THERAPEUTICS, INC. · Filed Feb 19, 2016
Insider Transaction Report
Form 4
Mitchum James P.
Director
Transactions
- Purchase
Common Stock
2016-02-02$2.68/sh+5,100$13,668→ 5,100 total(indirect: By Trust) - Purchase
Common Stock
2016-02-03$2.65/sh+13,900$36,835→ 19,000 total(indirect: By Trust)
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.66 to $2.69. The reporting person undertakes to provide to Tenax Therapeutics, Inc. (the ?Company?), any security holder of the Company, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.
- [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.60 to $2.69.